Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33989558

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Jun
First author
Caimi PF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Jun;22(6):741-742. doi: 10.1016/S1470-2045(21)00191-1.
    note
    Source null
    related pmid
    33989556
    relationship
    Comment in

Authors and identifiers

  1. name
    Caimi PF
    type
    Author
  2. name
    Ai W
    type
    Author
  3. name
    Alderuccio JP
    type
    Author
  4. name
    Ardeshna KM
    type
    Author
  5. name
    Hamadani M
    type
    Author
  6. name
    Hess B
    type
    Author
  7. name
    Kahl BS
    type
    Author
  8. name
    Radford J
    type
    Author
  9. name
    Solh M
    type
    Author
  10. name
    Stathis A
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Havenith K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Caimi PF
    type
    Author
  2. name
    Ai W
    type
    Author
  3. name
    Alderuccio JP
    type
    Author
  4. name
    Ardeshna KM
    type
    Author
  5. name
    Hamadani M
    type
    Author
  6. name
    Hess B
    type
    Author
  7. name
    Kahl BS
    type
    Author
  8. name
    Radford J
    type
    Author
  9. name
    Solh M
    type
    Author
  10. name
    Stathis A
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Havenith K
    type
    Author
bibliography ids
  1. nci-bib-ec3545160c57233c6ce9cbac
book metadata
content sha256
99df318444dde6a769f3947db8b19eacaffae5901215fd6d2a41a2679ac0315d
document type
citation
dois
  1. 10.1016/S1470-2045(21)00139-X
electronic publication date
display
2021 May 11
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33989558
immutable id
pubmed:33989558@99df318444dde6a769f3947db8b19eacaffae5901215fd6d2a41a2679ac0315d
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
6
name
The Lancet. Oncology
nlm unique id
100957246
pages
790-800
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Jun;22(6):741-742. doi: 10.1016/S1470-2045(21)00191-1.
    note
    Source null
    related pmid
    33989556
    relationship
    Comment in
outcomes validated
false
pmid
33989558
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
4684d6ec9a730ce6b6189fbd2fe7e3510158866405f2dc31d0f525333fb99703
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun
precision
month
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33989558/
title
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice